Advanced Parkinson's disease (PD) is characterized by massive degeneration of nigral dopaminergic neurons, dramatic motor and cognitive alterations, and presence of nigral Lewy bodies, whose main constituent is α-synuclein (α-syn). However, the synaptic mechanisms underlying behavioral and motor effects induced by early selective overexpression of nigral α-syn are still a matter of debate.

Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit / A. Tozzi, A. de Iure, V. Bagetta, M. Tantucci, V. Durante, A. Quiroga Varela, C. Costa, M. Di Filippo, V. Ghiglieri, E.C. Latagliata, M. Wegrzynowicz, M. Decressac, C. Giampà, J.W. Dalley, J. Xia, F. Gardoni, M. Mellone, O.M. El Agnaf, M.T. Ardah, S. Puglisi Allegra, A. Björklund, M.G. Spillantini, B. Picconi, P. Calabresi. - In: BIOLOGICAL PSYCHIATRY. - ISSN 0006-3223. - 79:5(2016 Mar 01), pp. 402-414. [10.1016/j.biopsych.2015.08.013]

Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit

F. Gardoni;M. Mellone;
2016

Abstract

Advanced Parkinson's disease (PD) is characterized by massive degeneration of nigral dopaminergic neurons, dramatic motor and cognitive alterations, and presence of nigral Lewy bodies, whose main constituent is α-synuclein (α-syn). However, the synaptic mechanisms underlying behavioral and motor effects induced by early selective overexpression of nigral α-syn are still a matter of debate.
English
Animal models; Cholinergic interneurons; Dopamine; Long-term potentiation; Parkinson’s disease; Striatum
Settore BIO/14 - Farmacologia
Articolo
Sì, ma tipo non specificato
Pubblicazione scientifica
1-mar-2016
Elsevier
79
5
402
414
13
Pubblicato
Periodico con rilevanza internazionale
crossref
pubmed
Aderisco
info:eu-repo/semantics/article
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit / A. Tozzi, A. de Iure, V. Bagetta, M. Tantucci, V. Durante, A. Quiroga Varela, C. Costa, M. Di Filippo, V. Ghiglieri, E.C. Latagliata, M. Wegrzynowicz, M. Decressac, C. Giampà, J.W. Dalley, J. Xia, F. Gardoni, M. Mellone, O.M. El Agnaf, M.T. Ardah, S. Puglisi Allegra, A. Björklund, M.G. Spillantini, B. Picconi, P. Calabresi. - In: BIOLOGICAL PSYCHIATRY. - ISSN 0006-3223. - 79:5(2016 Mar 01), pp. 402-414. [10.1016/j.biopsych.2015.08.013]
reserved
Prodotti della ricerca::01 - Articolo su periodico
24
262
Article (author)
no
A. Tozzi, A. de Iure, V. Bagetta, M. Tantucci, V. Durante, A. Quiroga Varela, C. Costa, M. Di Filippo, V. Ghiglieri, E.C. Latagliata, M. Wegrzynowicz, M. Decressac, C. Giampà, J.W. Dalley, J. Xia, F. Gardoni, M. Mellone, O.M. El Agnaf, M.T. Ardah, S. Puglisi Allegra, A. Björklund, M.G. Spillantini, B. Picconi, P. Calabresi
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0006322315006782-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 6.12 MB
Formato Adobe PDF
6.12 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/320180
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 71
social impact